All Industries

Top Therapeutics Companies

205 Therapeutics companies, sorted by total funding raised.

205

Companies

$30.6B

Combined Funding

Series A

Top Stage

Indexed tracks 205 Therapeutics companies that have collectively raised $30.6B in documented funding. The most-funded therapeutics companies tracked include Sana Biotechnology and Abogen Biosciences. Series A is the most common funding stage among therapeutics companies in this dataset.

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series D·$1.4B·Jun 2020
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$884.0M·Jul 2025
Candid Therapeutics

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...

San Diego, United States11–50Biotech, Therapeutics
Venture Round·$875.0M·Mar 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Edgewise TherapeuticsIPO

Clinical-stage biopharmaceutical company developing oral therapies for serious skeletal and cardi...

Boulder, United States51–200Biotech, Healthcare
Growth Equity·$585.0M·Apr 2025
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Gene Editing
Growth Equity·$528.0M·Feb 2026
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$520.0M·Dec 2018
Carmot TherapeuticsAcquired

Carmot Therapeutics was a clinical-stage biotech developing GLP-1-based therapeutics for obesity ...

Berkeley, United States11–50Biotech, Therapeutics
Series E·$497.0M·May 2023
RAPT TherapeuticsIPO

Clinical-stage biopharmaceutical developing immune-targeting therapeutics for inflammatory and im...

San Francisco, United States51–200Biotech, Healthcare
Private Equity·$497.0M·Oct 2025
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate Round·$492.3M·Feb 1990
ImmunomedicsClosed

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500biotechnology, oncology
Private Equity·$459.0M·May 2020
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Round·$453.5M·Jan 2026
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, GI Health
Venture Round·$450.3M·May 2023
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Development
Series C·$446.9M·Nov 2025
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series C·$446.8M·Oct 2025
Avalyn

Developing inhaled therapies to treat people with severe respiratory disease.

Boston, United States11–50Biotech, Healthcare
Series D·$434.5M·Jul 2025
Verve TherapeuticsAcquired

Develops one-time in vivo gene-editing medicines to prevent and treat atherosclerotic cardiovascu...

Boston, United States201–500Biotech, Drug Discovery
Series C·$428.5M·Oct 2024
Areteia TherapeuticsClosed

Clinical-stage biotechnology developing an oral eosinophil-maturation inhibitor (dexpramipexole) ...

Chapel Hill, United States11–50Biotech, Life Sciences
Series A·$425.0M·Feb 2024

Frequently Asked Questions

How many Therapeutics companies are tracked on Indexed?

Indexed tracks 205 Therapeutics companies, sorted by total funding raised.

How much funding have Therapeutics companies raised in total?

The Therapeutics companies tracked by Indexed have collectively raised $30.6B in documented funding.

What are the top-funded Therapeutics companies?

The most-funded Therapeutics companies tracked include Sana Biotechnology, Abogen Biosciences, Alnylam Pharmaceuticals.

Who are the top investors in Therapeutics?

Leading investors active in Therapeutics include NFX, EcoR1 Capital, Redmile Group.

Explore More

Other Industries